You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023182018
Dec 20233209
Jan 20244504
Feb 20242003
Mar 20242202
Apr 20241406
May 20241601
Jun 20241000
Jul 20241205
Aug 2024803
Sep 2024801
Oct 20241205
Nov 20241207
Dec 2024609
Jan 2025805
Feb 2025005
Mar 2025008
Apr 2025002
May 2025003
Jun 2025004
Total4070100